DEA: Marijuana Plant Seizures Spike, Arrests Fall in 2019

NORML

According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report , the agency and its law enforcement partners confiscated an estimated four million marijuana plants in 2019 – up from 2.8 By contrast, marijuana-related marijuana arrests compiled by the DEA fell to 4,718 in 2019 – a decrease of 16 percent from 2018’s totals. It was the second-lowest number of arrests reported by the DEA in the past decade.

DEA 177

NORML Formally Responds to DEA’s Proposed Changes to Marijuana Cultivation Rules

NORML

As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. To date, however, the DEA has failed to either affirm or reject any of the more than 30 applications it has received. ON BACKGROUND: The DEA has consistently discouraged the scientific investigation of cannabis, particularly with respect to its therapeutic properties. *

DEA 179

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DEA Report: Fewer Marijuana Seizures, But More Arrests In 2018

NORML

According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 However, while the total number of DEA-seized plants fell in 2018, seizures of indoor cannabis plants nearly doubled – rising from 304,000 plants in 2017 to just under 600,000 in 2018. LAW ENFORCEMENT assets DEA eradication legalization seizures

DEA 164

Hemp Litigation: DEA Sued Again

Canna Law Blog

The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids.

DEA 59

New lawsuit aims to force DEA to reschedule marijuana

Leafly

The DEA's five-part test to determine 'currently accepted medical use' is flawed, say the plaintiffs. The post New lawsuit aims to force DEA to reschedule marijuana appeared first on Leafly. Politics cannabis research Controlled Substances Act DEA medical marijuana rescheduling research Schedule I

DEA 87

NORML Says DEA’s Newly Proposed Bulk Cultivation Rules Are “Unduly Onerous, Expensive, and Impractical”

NORML

The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants. ” He added, “Further, the DEA has an incredibly poor track record in this arena – having for years now promised to expedite and streamline this process, but failing to deliver. In 2016, the DEA publicly announced that it would, for the first time, begin accepting applications from private entities wishing to grow research-grade cannabis.

DEA 161

DEA Warns Of Scammers Impersonating DEA Employees

Cannabis Law Report

One could argue at the moment that some US Federal Agencies have employees on the books who could be accused via their behaviour of scamming … Read More. Breaking News

DEA 56

Alert: Hemp Industry Members File New Federal Action Challenging DEA’s Regulatory Overreach

Cannabis Law Report

District Court to block the DEA from unlawfully criminalizing hemp production The lawsuit also highlights the DEA’s history of … Read More. The detailed complaint asks a U.S.

DEA 70

CVS Ignores DEA, Says It’s Already Selling CBD Products

Leafly

The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas.

DEA 87

DEA Says It Will Finally Let Others Grow Research-Grade Cannabis

Leafly

Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research

DEA 85

Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators

NORML

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications. However, most of those applications have been before DEA for several years, and the agency still has yet to provide any explicit timeline regarding when, if ever it intends to act on them.

DEA 101

DEA Assisting “to the Maximum Extent Possible” in the Federal Law Enforcement Response to Nationwide Protests — NORML Responds

NORML

As first reported by Buzzfeed News , the federal Drug Enforcement Administration (DEA) is expanding its law enforcement powers so that it can better assist “to the maximum extent possible in the federal law enforcement response” to the wave of ongoing, nationwide protests that have followed the killing of George Floyd by a member of the Minneapolis police. The DEA possesses the power to strictly enforce these violations of law.

DEA 195

It’s Time to Disband the DEA

Canna Law Blog

Buzzfeed News first reported that the Department of Justice expanded the Drug Enforcement Administration’s (DEA) jurisdiction in response to these protests. According to a DEA memorandum , the agency requested to expand its jurisdiction beyond federal drug laws to include the enforcement of “any federal crime committed as a result of protests over the death of George Floyd.” The DEA should be defunded or, better yet, disbanded, as we suggested way back in 2015.

DEA 63

DEA Interim Final Rule: What Is “Synthetically Derived THC”?

Canna Law Blog

In the context of “synthetic marijuana,” which the DEA describes as a “synthetic version of THC,” “synthetic THC” refers to a mixture of plant material sprayed with synthetic psychoactive chemicals.

DEA 83

ASA offers solution to DOJ research block: Our comments on the DEA’s proposed rules

Americans for Safe Access

On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes. In the comments, we suggest to federal legislators and the DEA that a new agency be established that has no history in prosecution of the activities of which the DEA seeks to become the sole enforcer.

DEA 163

Court: DEA Must Explain Its Failure to Act Upon Pending Marijuana Cultivation Applications

NORML

” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. Read NORML’s new op-ed, “Three years ago the DEA said they would remove roadblocks to cannabis research — they still haven’t, here.). “While most states recognize that cannabis has medical value, the DEA says otherwise, pointing to the absence of clinical research.

The Hemp Industry Responds to the DEA Rule With a Lawsuit

Canna Law Blog

On August 21, the Drug Enforcement Agency (the “DEA”) released an Interim Final Rule (the “ Rule ”), which, in part, suggests that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3

DEA 81

Scientists Sue DEA as it Drags its Feet and Hampers Cannabis Research

WeedAdvisor

Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. However, the DEA does not keep its staff employed without drugs to seize, with marijuana being an easy target. It could be argued that the DEA is hesitant for the sake of public safety. Here, DEA can act with little expenditure of resources.”.

Document: Court Orders California to Give Cannabis Records to DEA

Cannabis Law Report

The hemp has hit the fan…… California’s Bureau of Cannabis Control had refused to give the DEA those documents, arguing in court filings that the … Read More.

DEA 56

Ketamine Clinics and the DEA

Canna Law Blog

Today, we focus on some of the high-level requirements of the Drug Enforcement Agency (DEA) on clinics and their personnel. Ketamine is a Schedule III controlled substance, so the Controlled Substances Act (CSA) and federal regulations require that persons who manufacture, distribute, dispense, or otherwise deal in it obtain a DEA registration. In other words, not just anyone can obtain a DEA registration and dispense ketamine.

DEA 49

Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis?

Leafly

The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Science & Tech DEA nida researchYes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her. appeared first on Leafly.

DEA 74

DEA Launches Get Smart About Drugs Program For Schools Called Operation Prevention

Cannabis Law Report

Here’s the release the DEA sent out Designed for elementary, middle, and high school students, educators and parents nationwide, Operation Prevention is an important effort … Read More.

DEA 56

Statement: National Cannabis Industry Association Urges DEA to Rescind Interim Hemp Rule

Cannabis Law Report

The post Statement: National Cannabis Industry Association Urges DEA to Rescind Interim Hemp Rule first appeared on Cannabis Law Report. Organization submitted comments on proposed rule that oversteps Congress and would create confusion in hemp programs and 2018 Farm Bill WASHINGTON, D.C. –

DEA 52

The DEA Does Not Want You To Worry About Its New Hemp Rule. Don’t Take the Bait!

Canna Law Blog

Last week the Drug Enforcement Administration (DEA) issued a bad interim hemp rule. North Carolina attorney Rod Kight raised these concerns as well and he and I both spoke to Kyle Jaeger of Marijuana Moment about why we think are concerned about the DEA’s interim hemp rule.

DEA 81

Hemp Is Not Marijuana. Unless You Ask the DEA

Cannabis Law Report

DEA Tries to Define Hemp If you’re a hemp business, you probably understand the victory that came with Congress passing the 2018 Farm Bill. Unless You Ask the DEA first appeared on Cannabis Law Report. As … Read More. The post Hemp Is Not Marijuana.

DEA 43

The 2018 Farm Bill Does Not Support the DEA Interim Rule

Canna Law Blog

Unfortunately, the Drug Enforcement Administration (DEA) dropped a surprise interim hemp rule a few weeks ago, which took immediate effect and came as a shock to virtually everyone. The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids.

DEA 76

Hemp Industry Members File Lawsuit Against DEA, Challenging Rule That Could Have Far-reaching Consequences

Cannabis Law Report

Petition asks federal appeals court to review a rule the DEA issued last month, arguing the agency exceeded its authority and violated the 2018 farm … Read More.

DEA 56

DEA loosens rules on prescription CBD drug Epidiolex

Leafly

The post DEA loosens rules on prescription CBD drug Epidiolex appeared first on Leafly. Prescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year. Health Politics cannabidiol cbd Epidiolex GW Pharma GW Pharmaceuticals

DEA 65

Jurist – Article: How the DEA is Interfering with Religious Use of Psychedelics

Cannabis Law Report

The post Jurist - Article: How the DEA is Interfering with Religious Use of Psychedelics first appeared on Cannabis Law Report.

DEA 56

The DEA Deschedules Epidiolex

Cannabis Law Report

Well that came out of the blue in the midst of all the other dire news racing through the sector. Cannabis Business Times reports Effective … Read More. Breaking News

DEA 43

DEA Publishes Notice of Proposed Rulemaking On Marijuana Research

Cannabis Law Report

Cannabis research in the USA has been held back by the DEA’s stance on the issue, although it has been increasing the amount of cannabis it wants produced for research over the last couple of years. The DEA says the proposed rule will see additional registered growers and more diverse variety of marijuana strains available for research. Currently, the DEA has 37 pending applications to grow marijuana for research.

DEA 67

ICYMI: DEA and Cannabis Research Still Lousy Bedfellows

Canna Law Blog

Ole Miss got the cannabis study and research cultivation gig from the DEA (via a contract with the National Institute on Drug Abuse (NIDA)) in 1968. Seemingly, over a span of five decades, the DEA has maintained a research monopoly over limited amounts of standardized cannabis cultivated by a single academic institution in a very limited agricultural setting (per Ole Miss, it cultivates a little over 1,100 pounds from outdoor efforts and 22 pounds from indoor cultivation).

DEA Seizes 4M Marijuana Plants, Less Arrests in ’19

CannaMD

Drug Enforcement Agency (DEA) made far fewer cannabis-related arrests in 2019 than in previous years. Let’s take a closer look at what DEA data reveals. But despite all the DEA’s seizing and destroying, it’s clear that the average U.S. Good news! The U.S.

DEA 56

Duane Morris Article: DEA Issues Interim Final Rule Concerning Marijuana and Hemp

Cannabis Law Report

August 24, 2020 The DEA has not issued a warning or otherwise signaled a change in enforcement policy by issuing the interim final rule. The post Duane Morris Article: DEA Issues Interim Final Rule Concerning Marijuana and Hemp first appeared on Cannabis Law Report.

DEA 56

A Founder Looks at 50: Some Early, Unexpected Supporters of Marijuana Decriminalization

NORML

Of the several experts who were part of our regular “road show” at NORML during the 1970s, I wanted to focus today on two of them who were both unexpected and wonderfully effective -- Dr. Dorthy Whipple and former DEA Deputy Director John Finlator.

DEA Finally Agrees to Expand Marijuana Research Amid Pressure from Lawsuit

WeedAdvisor

Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. Their silence – despite claiming to be interested in more studies – led the Scottsdale Research Institute (SRI) to sue the DEA, demanding that they finally review the multiple applications sitting in limbo.

DEA 54

U.S. Federal Court Tells DEA to Evaluate Rescheduling Cannabis, in Light of its Medical Benefits

WeedAdvisor

The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis. The court’s sense of urgency finally puts judicial pressure on the DEA. The DEA is now forced to face the issue.

DEA 50